These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36790492)

  • 21. Direct Bypass Versus Indirect Bypass in Adult Moyamoya Angiopathy with Symptoms or Hemodynamic Instability: A Meta-analysis of Comparative Studies.
    Kim H; Jang DK; Han YM; Sung JH; Park IS; Lee KS; Yang JH; Huh PW; Park YS; Kim DS; Han KD
    World Neurosurg; 2016 Oct; 94():273-284. PubMed ID: 27423200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroid Autoantibodies and the Clinical Presentation of Moyamoya Disease: A Prospective Study.
    Lanterna LA; Galliani S; Zangari R; Conti L; Brembilla C; Gritti P; Colleoni ML; Bernucci C
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1194-1199. PubMed ID: 29305275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moyamoya: Indiana University Medical Center experience.
    Yilmaz EY; Pritz MB; Bruno A; Lopez-Yunez A; Biller J
    Arch Neurol; 2001 Aug; 58(8):1274-8. PubMed ID: 11493168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Encephaloduroarteriosynangiosis with Dural Inversion for Moyamoya Disease in a Pediatric and Adult Population-a Single-Center 20-Year Experience.
    Goren O; Hendrix P; Peled A; Kimchi G; Zauberman J; Griessenauer C; Feldman Z
    World Neurosurg; 2021 May; 149():e16-e21. PubMed ID: 33647488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and Genetic Risk Factors of Long-Term Outcomes after Encephaloduroarteriosynangiosis in Moyamoya Disease in China.
    Wang X; Zhang Z; Wang Y; Zou Z; Ta N; Hao F; Shang M; Li D; Zeng F; Han C; Nie F; Bao X; Yang Y; Wang H; Liang M; Yang R; Ou L; Wen L; Yang Z; Liu W; Duan L
    J Stroke Cerebrovasc Dis; 2021 Jul; 30(7):105847. PubMed ID: 33992965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
    Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
    J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Characteristics and Natural History of Quasi-Moyamoya Disease.
    Zhao M; Lin Z; Deng X; Zhang Q; Zhang D; Zhang Y; Wang R; Wang S; Jiang Z; Wang H; Zhao J
    J Stroke Cerebrovasc Dis; 2017 May; 26(5):1088-1097. PubMed ID: 28109734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moyamoya Disease in Children: Results From the International Pediatric Stroke Study.
    Lee S; Rivkin MJ; Kirton A; deVeber G; Elbers J;
    J Child Neurol; 2017 Oct; 32(11):924-929. PubMed ID: 28715924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of and Risk Factors for Cerebral Microbleeds in Moyamoya Disease and Syndrome in the American Population.
    Khan NI; Saherwala AA; Chen M; Salehian S; Salahuddin H; Welch BG; Pinho MC; Shang T
    Cerebrovasc Dis Extra; 2019; 9(3):139-147. PubMed ID: 31830749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short- and long-term outcomes of moyamoya patients post-revascularization.
    Teo M; Abhinav K; Bell-Stephens TE; Madhugiri VS; Sussman ES; Azad TD; Ali R; Esparza R; Zhang M; Steinberg GK
    J Neurosurg; 2023 May; 138(5):1374-1384. PubMed ID: 36272120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moyamoya disease: a comparison of long term outcome of conservative and surgical treatment in India.
    Sundaram S; Sylaja PN; Menon G; Sudhir J; Jayadevan ER; Sukumaran S; Sreedharan SE; Sarma S
    J Neurol Sci; 2014 Jan; 336(1-2):99-102. PubMed ID: 24183032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient Ischemic Attack in Pediatric Patients With Moyamoya Disease: Clinical Features, Natural History, and Predictors of Stroke.
    Zhao M; Zhang D; Wang S; Zhang Y; Wang R; Zhao J
    Pediatr Neurol; 2017 Oct; 75():48-54. PubMed ID: 28778481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcomes of pediatric moyamoya disease monitored to adulthood.
    Imaizumi T; Hayashi K; Saito K; Osawa M; Fukuyama Y
    Pediatr Neurol; 1998 Apr; 18(4):321-5. PubMed ID: 9588527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down syndrome and moyamoya: clinical presentation and surgical management.
    See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER
    J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indirect revascularization with the dural inversion technique for pediatric moyamoya disease: 20-year experience.
    Gadgil N; Lam S; Pyarali M; Paldino M; Pan IW; Dauser RC
    J Neurosurg Pediatr; 2018 Nov; 22(5):541-549. PubMed ID: 30117790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The natural clinical course of hemodynamically stable adult moyamoya disease.
    Cho WS; Chung YS; Kim JE; Jeon JP; Son YJ; Bang JS; Kang HS; Sohn CH; Oh CW
    J Neurosurg; 2015 Jan; 122(1):82-9. PubMed ID: 25361479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Revascularization Surgery in Patients with Ischemic-Type Moyamoya Disease: Predictors for Postoperative Stroke and Long-Term Outcomes.
    Yu L; Ma L; Huang Z; Shi Z; Wang R; Zhao Y; Zhang D
    World Neurosurg; 2019 Aug; 128():e582-e596. PubMed ID: 31059856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late (5-20 years) outcomes after STA-MCA anastomosis and encephalo-duro-myo-arterio-pericranial synangiosis in patients with moyamoya disease.
    Kuroda S; Nakayama N; Yamamoto S; Kashiwazaki D; Uchino H; Saito H; Hori E; Akioka N; Kuwayama N; Houkin K
    J Neurosurg; 2021 Mar; 134(3):909-916. PubMed ID: 32168480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moyamoya disease: a clinical spectrum, literature review and case series from a tertiary care hospital in Pakistan.
    Shoukat S; Itrat A; Taqui AM; Zaidi M; Kamal AK
    BMC Neurol; 2009 Apr; 9():15. PubMed ID: 19368734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical features and outcomes in patients with asymptomatic moyamoya disease--from the results of nation-wide questionnaire survey].
    Yamada M; Fujii K; Fukui M
    No Shinkei Geka; 2005 Apr; 33(4):337-42. PubMed ID: 15830539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.